Dentists in Dunlap, IL Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Rodney Earl Willey, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 11825 State Route 40, Suite 100, Dunlap, IL 61525 Phone: 309-243-8980 |
Dr. George M. Duncan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11825 State Route 40, Suite 100, Dunlap, IL 61525 Phone: 309-243-8980 Fax: 309-243-8983 |
Dr. Erin Patrick Shanahan, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 11825 State Route 40, Dunlap, IL 61525 Phone: 309-243-7702 Fax: 309-243-8188 |
Nizar N Merheb Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 11825 State Route 40, Dunlap, IL 61525 Phone: 309-243-8980 |
News Archive
Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease
Elan Corporation, plc and Transition Therapeutics, Inc today announced the results of a Phase 2 placebo-controlled study in 351 patients with mild to moderate Alzheimer's disease who received study drug for up to 18 months (Study AD201). Study subjects with MMSE scores between 16 and 26 received ELND005 oral doses of 250 mg, 1000 mg or 2000 mg twice daily or matching placebo. The study's cognitive (NTB) and functional (ADCS-ADL) co - primary endpoints did not achieve statistical significance.
Llama-derived nanobodies show neutralizing activity against SARS-CoV-2 variants of concern in vitro
A new study reports the development of nanoantibodies (nAbs) – also called or nanobodiesTM or single-domain antibodies – that effectively bind the SARS-CoV-2 spike protein from the ancestral Wuhan variant as well as the recently detected UK and South African variants.
Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute
Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).
BPA exposure can impact thyroid hormones in pregnant women and newborns
Bisphenol A (BPA), an estrogen-like compound that has drawn increased scrutiny in recent years, has been linked to changes in thyroid hormone levels in pregnant women and newborn boys, according to a new study by researchers at the University of California, Berkeley.
› Verified 5 days ago